Patent applications published 27 April 2011
Selected patent applications from the weekly European Patents Bulletin
- Method and kit for assessing viable cells
Chemometric 2312943*
- Deuterated benzylbenzene derivatives and methods of use
Theracos 2312944*
- Purine derivatives for treatment of Alzheimer’s disease
Merck Sharp & Dohme 2312945*
- Pyrimidine derivatives for treatment of Alzheimer’s disease
Merck Sharp & Dohme 2312946*
- TRPV4 antagonists
GlaxoSmithKline 2312947*
- 5-quinolinone and imidazopyridine compounds and use thereof
Southern Research Institute 2312948*
- N-heterocyclic M1 receptor positive allosteric modulators
Merck Sharp & Dohme 2312949*
- Compounds as kinase inhibitors
Advenchen Laboratories 2312950*
- Bicyclic compounds having antimitotic and/or antitumour activity and methods of use thereof
Duquesne University of the Holy Spirit 2312951*
- Antimicrobial compsn
Ambria Dermatology 2312952*
- Topical compsns comprising isonicotinamide
ELC Management 2313074*
- Oral compsns of clindamycin
Lupin 2313083*
- An intrauterine delivery system for contraception
Bayer Schering Pharma 2313084*
- Immunogenic amphipathic peptide compsns
Novartis 2313085*
- Controlled release topiramate formulations using intelligent polymers
Bioavail Laboratories International 2313086*
- Pharmaceutical dosage form for immediate release of an indolinone derivative
Boehringer Ingelheim International 2313087*
- Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
Mepha 2313088*
- Novel sulphur containing lipids for use as food supplement or as medicament
Pronova BioPharma Norge 2313090*
- Pharmaceutical compsns comprising RET inhibitors and methods for the treatment of cancer
Queen’s University at Kingston 2313091*
- Polyunsaturated fatty acids for improving vision
Pharma Marine 2313092*
- Methods and compsns of small molecule modulators of hepatocyte growth factor (scatter factor) activity
Angion Biomedica 2313093*
- New pyridine derivatives as leptin receptor modulator mimetics
AstraZeneca 2313094*
- Methods and products for treating proliferative diseases
The Regents of the University of Colorado 2313095*
- New compounds V
AstraZeneca AB 2313096*
- Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents
Nerviano Medical Sciences 2313097*
- Methods and systems for evaluating memory agents
Dart Neuroscience 2313098*
- Use of rifalazil to treat colonic disorders
Activbiotics Pharma 2313099*
- Inhibitors of the plasmoidal surface anion channel as antimalarials
The Unites States of America, as Represented By The Secretary, Department of Health and Human Services 2313100*
- Functional micelles for hard tissue targeted delivery of chemicals
The Board of Regents of the University of Nebraska 2313101*
- Bicyclic nucleosides and nucleotides and therapeutic agents
Biota Scientific Management; Boehringer Ingelheim International 2313102*
- Method of treating blepharitis
Inspire Pharmaceuticals 2313103*
- Thiolated chitosan gel
Medtronic 2313104*
- Soluble hybrid Fc receptors and related methods
ZymoGenetics 2313105*
- Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
Akerström, Bo; Hansson, Stefan; Olsson, Martin Lennarth; Olsson, Magnus 2313106*
- Catabolic agents
Smith & Nephew 2313107*
- Malaria vaccine of self-assembling polypeptide nanoparticles
United States Army as represented by the Secretary of the Army 2313108*
- IL6 immunotheraputics
Emergent Product Development Seattle 2313109*
- Effectors of PAR-2 activation and their use in the modulation of inflammation
Boehringer Ingelheim International; Giblin, Patricia; Miller, Sandra; Pracht, Catrin; Boxhammer, Rainer; Magram, Jeanne 2313110*
- Toll-like receptor agonist formulations and their use
VentiRx Pharmaceuticals 2313111*
- Neutralising anti-influenza A virus antibodies and uses thereof
Institute for Research in Biomedicine 2313112*
- Metered dose inhaler
Neo-Inhalation Products 2313113*
- A drug powder for inhalation administration and a process thereof
Universita Di Parma 2313114*
- Polymeric delivery systems for active agents
Technical University of Munich; University of Nebraska Medical Centre 2313115*
- Improved bacterial polysaccharide-polypeptide conjugate compsns
Intercell AG 2313116*